Save your place

Sign in to WhoBought

Please try again later.

Merck & Co., Inc. (MRK) institutional ownership

Latest close $126.27 Jul 21, 2026
Market cap$319.5B 52-week range SectorHealthcare
Funds holding · Q1 2026
3,445
reported MRK position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $2.9B
1,739 buyers · 1,706 sellers

Merck & Co., Inc. (MRK) price and institutional activity

Dates

Q1 2026

$12.2B bought by 1739 investors
JPMorgan Chase & Co$2.7BBlackRock$777M +1,737 more
$15.2B sold by 1706 investors
Norges-$4.4BArrowstreet Capital, Limited Partnership-$808M +1,704 more
Bought Sold Totals per quarter; hover a bar for the names.

Merck & Co., Inc. (MRK) institutional activity · 3,445

Investor Type Est. change Change Δ Own Date
Norges · Exited −$4.4B
Change −38.0M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$4.4B −38.0M −100.0% Q1 2026
JPMorgan Chase & Co · Added +$2.7B
Change +23.8M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +$2.7B +23.8M Q1 2026
Arrowstreet Capital, Limited Partnership · Reduced −$808M
Change −7.0M Date Q1 2026
Arrowstreet Capital, Limited Partnership Reduced· Q1 2026 −$808M −7.0M Q1 2026
BlackRock · Added +$777M
Change +6.7M Date Q1 2026
BlackRock Added· Q1 2026 +$777M +6.7M Q1 2026
UBS Group AG · Reduced −$605M
Change −5.2M Date Q1 2026
UBS Group AG Reduced· Q1 2026 −$605M −5.2M Q1 2026
Millennium Management LLC · Reduced −$557M
Change −4.8M Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −$557M −4.8M Q1 2026
Pacer Advisors, Inc. · Exited −$502M
Change −4.4M Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −$502M −4.4M −100.0% Q1 2026
T. Rowe Price Associates · Added +$495M
Change +4.3M Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +$495M +4.3M Q1 2026
Massachusetts Financial Services Co · Reduced −$478M
Change −4.1M Date Q1 2026
Massachusetts Financial Services Co Reduced· Q1 2026 −$478M −4.1M Q1 2026
Los Angeles Capital Management LLC · Reduced −$428M
Change −3.7M Date Q1 2026
Los Angeles Capital Management LLC Reduced· Q1 2026 −$428M −3.7M Q1 2026
FMR LLC · Added +$424M
Change +3.7M Δ Own +9.0% Date Q1 2026
FMR LLC Added· Q1 2026 +$424M +3.7M +9.0% Q1 2026
Nuveen, LLC · Added +$362M
Change +3.1M Date Q1 2026
Nuveen, LLC Added· Q1 2026 +$362M +3.1M Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −$346M −3.0M −44.0% Q1 2026
Dimensional · Added +$342M
Change +3.0M Date Q1 2026
Dimensional Added· Q1 2026 +$342M +3.0M Q1 2026
Bank of America Corp · Added +$337M
Change +2.9M Date Q1 2026
Bank of America Corp Added· Q1 2026 +$337M +2.9M Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 3445

Famous investor activity in Merck & Co., Inc. (MRK)

Merck & Co., Inc. (MRK) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Seidman Christine E. · Director Grant (A) $8K
Price $128.50 Qty 63 Owned 21K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Seidman Christine E. Director Grant (A) $128.50 63 $8K 21K Jun 30, 2026 Jul 1, 2026
Karsanbhai Surendralal Lanca · Director Grant (A) $16K
Price $128.50 Qty 126 Owned 6K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Karsanbhai Surendralal Lanca Director Grant (A) $128.50 126 $16K 6K Jun 30, 2026 Jul 1, 2026
Coe Mary Ellen · Director Grant (A) $30K
Price $128.50 Qty 233 Owned 32K Trade date Jun 30, 2026 Filed date Jul 1, 2026
Coe Mary Ellen Director Grant (A) $128.50 233 $30K 32K Jun 30, 2026 Jul 1, 2026
Warden Kathy J. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Warden Kathy J. Director Grant (A) $118.72 2K $220K 18K May 29, 2026 Jun 2, 2026
Karsanbhai Surendralal Lanca · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 5K Trade date May 29, 2026 Filed date Jun 2, 2026
Karsanbhai Surendralal Lanca Director Grant (A) $118.72 2K $220K 5K May 29, 2026 Jun 2, 2026
Coe Mary Ellen · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 32K Trade date May 29, 2026 Filed date Jun 2, 2026
Coe Mary Ellen Director Grant (A) $118.72 2K $220K 32K May 29, 2026 Jun 2, 2026
Thulin Inge G. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 27K Trade date May 29, 2026 Filed date Jun 2, 2026
Thulin Inge G. Director Grant (A) $118.72 2K $220K 27K May 29, 2026 Jun 2, 2026
Seidman Christine E. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 21K Trade date May 29, 2026 Filed date Jun 2, 2026
Seidman Christine E. Director Grant (A) $118.72 2K $220K 21K May 29, 2026 Jun 2, 2026
Russo Patricia F. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 62K Trade date May 29, 2026 Filed date Jun 2, 2026
Russo Patricia F. Director Grant (A) $118.72 2K $220K 62K May 29, 2026 Jun 2, 2026
Rothman Paul · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 35K Trade date May 29, 2026 Filed date Jun 2, 2026
Rothman Paul Director Grant (A) $118.72 2K $220K 35K May 29, 2026 Jun 2, 2026
Mayo Stephen · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 15K Trade date May 29, 2026 Filed date Jun 2, 2026
Mayo Stephen Director Grant (A) $118.72 2K $220K 15K May 29, 2026 Jun 2, 2026
Lavizzo-Mourey Risa J. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 18K Trade date May 29, 2026 Filed date Jun 2, 2026
Lavizzo-Mourey Risa J. Director Grant (A) $118.72 2K $220K 18K May 29, 2026 Jun 2, 2026
Glocer Thomas H. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 111K Trade date May 29, 2026 Filed date Jun 2, 2026
Glocer Thomas H. Director Grant (A) $118.72 2K $220K 111K May 29, 2026 Jun 2, 2026
Craig Pamela J. · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 35K Trade date May 29, 2026 Filed date Jun 2, 2026
Craig Pamela J. Director Grant (A) $118.72 2K $220K 35K May 29, 2026 Jun 2, 2026
Baker Douglas M. Jr · Director Grant (A) $220K
Price $118.72 Qty 2K Owned 12K Trade date May 29, 2026 Filed date Jun 2, 2026
Baker Douglas M. Jr Director Grant (A) $118.72 2K $220K 12K May 29, 2026 Jun 2, 2026
15 of 100
15 of 100 Sign in to continue to older insider transactions.

Merck & Co., Inc. (MRK) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 244.8M
% of shares outstanding 9.7% Filing date Feb 13, 2024
Vanguard Group Inc 244.8M 9.7% Feb 13, 2024
BlackRock Inc. 201.8M
% of shares outstanding 8.0% Filing date Jan 26, 2024
BlackRock Inc. 201.8M 8.0% Jan 26, 2024
Vanguard Capital Management 186.3M
% of shares outstanding 7.5% Filing date Apr 30, 2026
Vanguard Capital Management 186.3M 7.5% Apr 30, 2026
3 of 3

Merck & Co., Inc. (MRK) ownership FAQ

Who owns MRK?

3,445 reporting institutions disclosed MRK position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.